Notes and Lines of Credit Payable - Additional Information (Detail) - USD ($)		1 Months Ended	2 Months Ended	6 Months Ended		12 Months Ended
	Oct. 14, 2015	Mar. 28, 2014	Mar. 28, 2014	Sep. 30, 2015	Sep. 30, 2014	Mar. 31, 2015	Jun. 30, 2015	Jul. 21, 2014	Dec. 20, 2013	Oct. 15, 2013
Senior Secured Note [Line Items]
Debt, maturity date				Mar. 28, 2019
Class of warrant or right, number of securities called by warrants or rights								100,000
Debt Instrument, Unamortized Discount		$ 990,838	$ 990,838	$ 217,316		$ 1,060,401
Amortization Of Debt Discount Premium				$ (47,875)	$ 177,963
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0.00%
Derivative Liability, Current		$ 6,685,402	6,685,402	$ 1,315,846		0	$ 1,477,308
Debt Issuance Cost			26,117
Increase (Decrease) in Derivative Liabilities			999,724
Increase (Decrease) in Other Accrued Liabilities			$ 35,004
Private Placement [Member]
Senior Secured Note [Line Items]
Stock Issued During Period, Shares, New Issues	1,111,111
Stock Issued During Period, Value, New Issues	$ 10,000,000
Los Angeles Lung Center [Member]
Senior Secured Note [Line Items]
Line of credit facility amount outstanding				230,000
Bay Area Hospitalist Associates [Member]
Senior Secured Note [Line Items]
Line of credit facility amount outstanding				150,000
2014 NNA Financing
Senior Secured Note [Line Items]
Amortization Of Debt Discount Premium				20,930
Related Party Costs				235,119
Deferred Finance Costs Net				176,218
Proceeds From Issuance Of Debt Instruments On Fair Value				$ 9,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate				2.31%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				71.40%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price				$ 4.50
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				50.00%
Stock Issued During Period Value For Financing				$ 899,739
Discount On Shares Issuance				1,100,261
Discount On Term Loan				1,254,363
Fair Value Of Warrant Liabilities				$ 2,354,624
Expected term				7 years
Amortization Of Debt Discount				$ 51,072
Amortization Of Debt Discount Premium Related To Equity				7,998
Term Loan Value Under Agreement				$ 5,745,637
NNA
Senior Secured Note [Line Items]
Term Loan accrued interest				8.00%
Investment Agreement
Senior Secured Note [Line Items]
Warrants To Purchase Common Stock				200,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 20.00
Pledge and Security Agreement
Senior Secured Note [Line Items]
Securities Owned and Pledged as Collateral, Description				Pledged interests as of the date of the Pledge and Security Agreement include 100% of AMM, PCCM, VMM common stock and 72.77% of ApolloMed ACO common stock.
Revolving Credit Facility
Senior Secured Note [Line Items]
Revolving line of credit carrying amount				$ 100,000						$ 2,000,000
Line of credit facility amount outstanding				$ 94,764
Line of credit facility, interest rate description				prime rate (as defined) plus 4.50% (7.75% per annum at September 30, 2015 and at March 31, 2015),
Line of credit facility, frequency of payment and payment terms				interest only is payable monthly, and the line of credit matures June 5, 2016.
Proceeds from Lines of Credit				$ 1,000,000		$ 1,000,000
Revolving Credit Facility | Maximum
Senior Secured Note [Line Items]
Line of credit facility, maximum borrowing capacity									$ 4,000,000
Revolving Credit Facility | Minimum
Senior Secured Note [Line Items]
Line of credit facility, maximum borrowing capacity									$ 2,000,000
Convertible Notes Payable
Senior Secured Note [Line Items]
Debt, interest rate		8.00%	8.00%
Debt, maturity date		Mar. 28, 2019
Debt Instrument, Fee Amount		$ 2,000,000	$ 2,000,000
Debt Instrument, Convertible, Terms of Conversion Feature		The Company may redeem amounts outstanding under the Convertible Note on 60 days prior notice to NNA.
Debt Instrument, Convertible, Conversion Price		$ 10.00	$ 10.00
NNA Warrants
Senior Secured Note [Line Items]
Debt Issuance Cost			$ 176,218
NNA Warrants | Investment Agreement
Senior Secured Note [Line Items]
Warrants To Purchase Common Stock				300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 10.00
Senior secured note | SpaGus
Senior Secured Note [Line Items]
Senior notes				$ 500,000
Term Loan
Senior Secured Note [Line Items]
Line of credit facility amount outstanding		$ 7,000,000	7,000,000
Class of warrant or right, number of securities called by warrants or rights				300,000
Repayment of first year term loan				$ 87,500
Repayment of second year term loan				122,500
Repayment of third year term loan				122,500
Repayment of fourth year term loan				175,000
Repayment of fifth year term loan				210,000
Debt Instrument, Unamortized Discount				1,305,435
Debt Instrument, Fee Amount				$ 80,000
Revolving Loan [Member]
Senior Secured Note [Line Items]
Line of credit facility amount outstanding		$ 1,000,000	$ 1,000,000
Line of credit facility, interest rate description				three month LIBOR plus 6.0%
Term Loan And Revolving Loan [Member]
Senior Secured Note [Line Items]
Debt, maturity date				Mar. 28, 2019
Line of Credit Facility, Expiration Date				Mar. 28, 2019